Impact of Letermovir Prophylaxis on the Pattern of CMV Events and Its Association with Relapse in Allogenic HSCT Recipients for Myelodysplastic Syndromes

Prevymis (letermovir) - Merck (MSD)

Sin Young Park 1; Ja Min Byun 1, 2; Youngil Koh 1, 2; Dong-Yeop Shin 1, 2; Inho Kim 1, 2; Sung-Soo Yoon 1, 2; Junshik Hong 1, 2

Sep 3, 2025